- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02269787
TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Annually, about 25,000 Veterans receive inpatient detoxification (detox) for substance use disorders (SUDs). Detox is not SUD treatment; it is the medical management of withdrawal to prevent complications, which may be fatal. Detox inpatients who enter SUD treatment and peer-based mutual-help groups (e.g., Alcoholics Anonymous) have much better outcomes (less substance use, HIV/HCV risk behaviors, homelessness, rehospitalizations, Emergency Department visits) than those who do not. However, because of their unique characteristics (severe and chronic addictions, co-morbidities, lack of resources, self- and provider-perceptions as unsuitable for treatment), most Veterans discharged from inpatient detox do not enter SUD treatment. For many Veterans, a pattern of repeated inpatient detox, with each episode incurring a higher risk of overdose, occurs. Therefore, in its Uniform Services Handbook, Mental Health Operations places major emphasis on increasing the rate of SUD treatment initiation and engagement following detox to benefit Veterans' outcomes and prevent more use of costly health care.
The primary objective of this project is to implement and evaluate Enhanced Telephone Monitoring (ETM) as a new and innovative telehealth intervention to facilitate the transition from inpatient detox to SUD specialty treatment (residential, outpatient, pharmacotherapy), thereby improving Veterans' outcomes and decreasing VA health care costs. In a randomized trial at two sites (VA Palo Alto and Boston), investigators hypothesize that patients receiving ETM, compared to patients in usual care (UC), will be more likely to enter and engage in SUD treatment and mutual-help, have better SUD and related outcomes, and have fewer and delayed acute care episodes. This project will also conduct a formative evaluation of how to implement ETM VA-wide, focusing on diverse subgroups of Veterans. Further, it will conduct a Budget Impact Analysis (BIA) to determine the impact of ETM on total costs of VA care. Investigators hypothesize that the higher costs associated with ETM (because patients will engage in SUD treatment) will be more than offset by its lower costs of acute care.
Patients in the ETM condition will receive an in-person session while in detox, followed by coaching over the telephone for 3 months after discharge. The intervention will incorporate Motivational Interviewing, and Contracting, Prompting, and Reinforcing, to provide support while waiting for treatment, and facilitate entry into treatment and mutual-help, and improved responses to crises. Patients will be assessed at baseline and 3 and 6 months post-discharge for outcomes and non-VA health care; VA health care will be assessed with VA databases. GLMM analyses will be conducted to compare the UC and ETM groups on course of outcomes over time. The formative evaluation to inform the implementation of ETM will use the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. Semi-structured interviews will be conducted with inpatient detox staff and patients to yield facilitators of ETM implementation and modifiable barriers with associated action plans. For the BIA, costs of ETM will be measured through microcosting methods. For patients in both the ETM and UC groups, all inpatient, residential, outpatient, and pharmacy care will be measured from VA utilization and cost files.
In summary, Mental Health Operations is committed to eradicating the dangerous, costly pattern of Veterans obtaining inpatient detox services but not receiving the SUD treatment they need. Telehealth interventions, a promising way to improve treatment access and outcomes by SUD patients, have not been utilized with the challenging population of detox inpatients before. In accordance with others in this CREATE, this project will help to accomplish Mental Health Operations' goal of implementing the Uniform Handbook by increasing Veterans' access to, engagement in, and benefit from, SUD treatment services, particularly among Veterans who are using VA medical services and need SUD services but are not receiving them.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
Palo Alto, California, États-Unis, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Beginning an episode of inpatient detoxification at the Boston or Palo Alto Veterans Affairs medical facilities, and
- have ongoing access to cell phone or land line telephone
Exclusion Criteria:
- Significant cognitive impairment
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Enhanced Telephone Monitoring
Detox inpatients in the ETM condition will be expected to complete one 15-minute telephone call per week for 12 weeks.
|
Detox inpatients in the ETM condition will be expected to complete one session while in detox and one 15-minute telephone call per week for 12 weeks (plus usual care).
Autres noms:
|
|
Aucune intervention: Usual Care
Patients in the usual care condition will receive the care they would receive in the absence of a research project.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Percent of Participants Who Had an Additional Inpatient Detoxification
Délai: 6-month follow-up
|
Percent that had (yes) an additional inpatient detoxification 6 months following baseline assessment- additional inpatient detoxification was dichotomous, yes or no.
|
6-month follow-up
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Christine Timko, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CRE 12-010
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Soins habituels
-
University of ArizonaPas encore de recrutementGroupe 1: Coins des transporteurs (CC) suivis des soins de la peau à la peau (SSC) suivis d'un choix de famille | Groupe 2: Skin-to-Skin Care (SSC) suivi des soins des transporteurs (CC) suivis d'un choix de famille
-
Parc de Salut MarHospital del Mar Research Institute (IMIM); COIB, Col·legi d'Infermers i infermeres... et autres collaborateursComplétéRelations infirmières-médecins | Stress professionnel | Champ d'application de l'infirmière praticienne | Environnement de travail des infirmières | Programme Committed Centers With Excellence in Care (CCEC®) | Attitudes des infirmières en matière de pratique fondée sur des données probantesEspagne
-
Icahn School of Medicine at Mount SinaiChildren's Hospital of PhiladelphiaRecrutement
-
Gardiens de ViesInstitut Pasteur; MagIA DiagnosticsPas encore de recrutementPerformance | Virus de l'hépatite C (VHC) | Syphilis | VHB (virus de l'hépatite B) | VIH - Virus de l'Immunodéficience Humaine | Transmission mère-enfant | Test de Point of Care STI | TRAITEMENT B
Essais cliniques sur Enhanced Telephone Monitoring
-
Universitätsmedizin MannheimComplétéImmuno-monitoringAllemagne
-
Centre d'Investigation Clinique et Technologique...ComplétéMaladie neuromusculaire | Ventilation mécanique domestiqueFrance
-
Sun Yat-sen UniversityHangzhou Repugene Technology Co., Ltd.ComplétéCancer du poumon non à petites cellulesChine
-
Azienda Ospedaliero-Universitaria di ParmaRegione Emilia-RomagnaComplétéDiabète sucré, type 1Italie
-
Sun Yat-sen UniversityComplété
-
University of WashingtonNational Institute of Mental Health (NIMH); Kenyatta National Hospital; University...RecrutementSciences de la mise en œuvre | Infection à VIH chez les adolescents | Stratégies de mise en œuvre | Transition vers les soins pour adultesKenya
-
Arizona Heart InstituteInconnueAnévrisme de l'aorte abdominaleÉtats-Unis
-
Philips Clinical & Medical Affairs GlobalRecrutementSoins intensifs | Cathéter de l'artère pulmonaire (PAC) | Cathéter de Swan-GanzÉtats-Unis, Allemagne
-
Yale UniversityComplété
-
University College CorkOsypka Medical, Berlin, GermanyRésiliéHémorragie intraventriculaire | Instabilité hémodynamique | Hypotension et choc | Hypoperfusion | Fonction cardiaque | Transition circulatoireIrlande